product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
NRF2
catalog :
14596
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
D9J1B
reactivity :
human, mouse
application :
immunocytochemistry, immunoprecipitation, immunohistochemistry - paraffin section
citations: 3
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; mouse; 1:1000; loading ...; fig 4a
Zhang J, Zhang J, Ni H, Wang Y, Katwal G, Zhao Y, et al. Downregulation of XBP1 protects kidney against ischemia-reperfusion injury via suppressing HRD1-mediated NRF2 ubiquitylation. Cell Death Discov. 2021;7:44 pubmed publisher
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 7c
Horiuchi M, Taguchi K, Hirose W, Tsuchida K, Suzuki M, Taniyama Y, et al. Cellular Nrf2 Levels Determine Cell Fate during Chemical Carcinogenesis in Esophageal Epithelium. Mol Cell Biol. 2021;41: pubmed publisher
  • immunoprecipitation; human; loading ...; fig 4e
Sanghvi V, Leibold J, Mina M, Mohan P, Berishaj M, Li Z, et al. The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase. Cell. 2019;178:807-819.e21 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.